Passive smoking and platelet thromboxane

Author： Karanikas G.   Schmid P.   Kritz H.   Pirich C.   Stamatopoulos Y.   Peskar B.A.   Sinzinger h.  

Publisher： Elsevier

ISSN： 0049-3848

Source： Thrombosis Research, Vol.81, Iss.4, 1996-02, pp. : 451-460

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Habitual smoking causes an abnormality in platelet thromboxane A2 metabolism and results in an altered susceptibility to aspirin effects

By Weber Artur-Aron   Liesener Sven   Schanz Andrea   Hohlfeld Thomas   Schror Karsten  

Platelets, Vol. 11, Iss. 3, 2000-05 ,pp. : 177-182

Informa Healthcare

Access to resources Recommend Favorite

Passive Smoking and Coronary Heart Disease

By  

Current Vascular Pharmacology, Vol. 2, Iss. 2, 2004-04 ,pp. : 175-182

Bentham Science Publishers

Access to resources Recommend Favorite

Active and Passive Cigarette Smoking and Risk of Intracranial Meningioma

By  

Neuroepidemiology, Vol. 24, Iss. 3, 2005-04 ,pp. : 117-122

Karger

Access to resources Recommend Favorite

Differential actions of naftopidil, doxazosin and nifedipine on platelet thromboxane generation and platelet-derived growth factor efflux in vitro

By Alarayyed N.A.   Prichard B.N.C.   Betteridge D.J.   Smith C.C.T.  

Platelets, Vol. 13, Iss. 5-6, 2002-08 ,pp. : 267-271

Informa Healthcare

Access to resources Recommend Favorite

Determination of thromboxane formation, soluble CD40L release and thrombopoietin clearance in apheresis platelet concentrates

By Wenzel Folker   Baertl Anja   Hohlfeld Thomas   Zimmermann Norbert   Weber Artur Aron   Lorenz Horst   Giers Günther  

Platelets, Vol. 23, Iss. 2, 2012-03 ,pp. : 150-156

Informa Healthcare

Access to resources Recommend Favorite